# A Phase I Clinical Study of ART101 Injection in Healthy Adult Subjects

> **NCT07529600** · PHASE1 · COMPLETED · sponsor: **Arnatar Therapeutics, Inc.** · enrollment: 40 (actual)

## Conditions studied

- Hypertension (HTN)

## Interventions

- **DRUG:** Subcutaneous (SC) single dose

## Key facts

- **NCT ID:** NCT07529600
- **Lead sponsor:** Arnatar Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-18
- **Primary completion:** 2025-12-19
- **Final completion:** 2025-12-19
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07529600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07529600, "A Phase I Clinical Study of ART101 Injection in Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07529600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*